Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MRI Screening in Men at High Risk of Developing Prostate Cancer

NCT05608694 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT05608694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05608694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MRI Screening in Men at High Risk of Developing Prostate Cancer
Lead sponsor
University of Chicago
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 2, 2022
Completion date
March 1, 2039
Enrollment
250 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer screening